Open Peer Review Reports for: Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study
Pre-publication versions of this article are available by contacting info@biomedcentral.com.
| Original Submission | ||
|---|---|---|
| 14 Feb 2015 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Author responded | Author comments | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Author responded | Author comments | |
| Reviewed | Reviewer Report | |
| Reviewed | Reviewer Report | |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Author responded | Author comments | |
| Reviewed | Reviewer Report | |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 1 Oct 2015 | Editorially accepted | |
| 8 Oct 2015 | Article published | 10.1186/s12885-015-1673-3 |
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.
You can find further information about the peer review system here.
